Live Quote · NASDAQMYGNHealthcare· Medical - Diagnostics & Research

Myriad Genetics, Inc.

$5.99 0.17%($-0.01)
TickerSpark Score
58/100
Mixed
80
Valuation
40
Profitability
15
Growth
76
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MYGN research report →

52-Week Range49% of range
Low
$3.53
Current
$5.99
High
$8.59
Company Overviewwww.myriad.com

About the company

Myriad Genetics, Inc. , a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics.

CEO
Samraat S Raha
IPO
1995
Employees
2,725
HQ
Salt Lake City, UT, US

Price Chart

+6.39% · this period
$8.18$5.87$3.55Jul 02Dec 31Jul 02
Valuation
Market Cap
$565.74M
P/E
-1.39
P/S
0.68
P/B
1.66
EV/EBITDA
-1.95
Div Yield
0.00%
Profitability
Gross Margin
69.96%
Op Margin
-46.26%
Net Margin
-48.24%
ROE
-109.09%
ROIC
-69.65%
Growth & Income
Revenue
$824.50M · -1.56%
Net Income
$-365,900,000 · -187.43%
EPS
$-3.96 · -180.85%
Op Income
$-67,800,000
FCF YoY
33.33%
Performance & Tape
52W High
$8.59
52W Low
$3.53
50D MA
$4.52
200D MA
$5.79
Beta
1.64
Avg Volume
1.63M

Get TickerSpark's AI analysis on MYGN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 23, 26Skovronsky Danielother0
Jun 11, 26Raha Samraat S.other3,542
Jun 11, 26Donnelly Brian Jother5,000
Jun 8, 26Kumar Rashmisell15,000
Jun 4, 26Skovronsky Danielother59,701
Jun 4, 26Newcomer Lee Nisleyother59,701
Jun 4, 26Davis Mark Stevenother59,701
Jun 4, 26Phanstiel S. Louiseother59,701
Jun 4, 26Dreismann Heinrichother59,701
Jun 4, 26Reitan Colleen Fother59,701
Coverage · MYGN

Our MYGN coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on MYGN yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate MYGN report →
Internal Compare

Similar companies

Peers in the same neighborhood.